Rheumatoid Arthritis: How Infusion Therapy Fits Into Treatment
When joint pain and stiffness don't respond to first-line medications, biologic infusions can target the inflammation at its source. Here's what that actually looks like.
What is rheumatoid arthritis?
Rheumatoid arthritis (RA) is a chronic autoimmune condition in which the immune system mistakenly attacks the lining of the joints, leading to inflammation, pain, and, over time, joint damage. Unlike the wear-and-tear of osteoarthritis, RA tends to affect joints symmetrically (both hands, both wrists, both knees) and often brings a level of fatigue that goes well beyond the joints themselves.
RA affects roughly 1 in 100 people worldwide and most commonly appears between the ages of 35 and 60, though it can develop at any age, including in children. Morning stiffness that lasts more than 30 minutes, swelling in the small joints of the hands and feet, and persistent fatigue are among the most common early signs.
Why some patients move to infusion therapy
Most people with RA start on a conventional disease-modifying antirheumatic drug (DMARD), such as methotrexate. When that isn't enough to control symptoms and prevent joint damage, a rheumatologist may recommend a biologic: a class of medication built to target very specific parts of the immune system that drive inflammation, rather than suppressing the immune system broadly.
Several of the most effective biologics for rheumatoid arthritis are only available as infusion therapy, delivered directly into the bloodstream through an IV. Because the medication bypasses the digestive system entirely, it reaches full effectiveness more reliably than an oral drug, and dosing can be spaced out, with some infusion biologics needed as infrequently as once every four to eight weeks.
Common infusion medications for RA include TNF inhibitors like infliximab (Remicade) and its biosimilars (Inflectra, Renflexis), T-cell modulators like abatacept (Orencia), B-cell therapies like rituximab (Rituxan), and IL-6 inhibitors like tocilizumab (Actemra), each targeting a different piece of the inflammatory process. Your rheumatologist will match the medication to your specific case.
What to expect during an infusion visit
Before your infusion begins, a nurse checks your temperature, blood pressure, and pulse, and these vitals are monitored throughout the visit. Depending on the medication, the infusion itself can take anywhere from 30 minutes to a few hours, time many patients spend reading, working, or simply resting in a recliner.
You may be given a small dose of an antihistamine or other medication beforehand to reduce the chance of an infusion reaction. Most reactions, when they happen, are mild (some redness at the IV site, a brief headache, or mild nausea) and resolve quickly. Because you're monitored by clinical staff the entire time, more significant reactions are caught early.
Symptom improvement isn't usually immediate. Depending on the medication, it can take anywhere from a couple of weeks to a few months of consistent treatment before you notice a meaningful difference in pain and stiffness.
Why physician oversight matters
Because biologics work by adjusting the immune system, ongoing monitoring matters: watching for infection risk, reviewing lab work, and adjusting the treatment plan as needed. An infusion suite with a physician on site, rather than just on call, means any concerns during or after treatment can be addressed immediately rather than waiting for the next scheduled appointment.
Considering infusion therapy for RA?
Our physician-led team works directly with your rheumatologist to coordinate care, handle prior authorization, and make every visit as comfortable as possible.
Call (551) 336-5580See all conditions we treat at Specialty Infusions →
This article is for general educational purposes and is not a substitute for medical advice. Treatment decisions should always be made with your physician based on your individual diagnosis and health history.